Novel Technologies for Vaccine Development
Springer Wien (Verlag)
978-3-7091-1980-8 (ISBN)
Reverse Genetics Approaches for Rational Design of Inactivated and Live-Attenuated Influenza Vaccines.- Viral-Vectored Vaccines to Control Pathogenic Filoviruses.- Alphavirus Replicon Vectors for Prophylactic Applications and Cancer Intervention.- Current Status and Future of Polio Vaccines and Vaccination.- Current Status of Hantavirus Vaccines Development.- Experimental DNA-Launched Live Attenuated Vaccines against Infections Caused by Flavi- and Alphaviruses.- Sugar-Based Immune Adjuvants for Use in Recombinant, Viral, Vector, DNA and Other Styles of Vaccines.- Adenovirus-based Vectors for the Development of Prophylactic and Therapeutic Vaccines.- Radiovirotherapy for the Treatment of Cancer.- TRICOM Poxviral-Based Vaccines for the Treatment of Cancer.- The Use of Oncolytic Herpesvirus for the Treatment of Cancer.- SA-4-1BBL; A Novel form of the 4-1BB Costimulatory Ligand as an Adjuvant Platform for the Development of Subunit Cancer Vaccines.
Erscheinungsdatum | 03.08.2016 |
---|---|
Zusatzinfo | XIV, 386 p. 35 illus., 33 illus. in color. |
Verlagsort | Vienna |
Sprache | englisch |
Maße | 155 x 235 mm |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie |
Medizin / Pharmazie ► Pharmazie | |
Studium ► Querschnittsbereiche ► Infektiologie / Immunologie | |
Naturwissenschaften ► Chemie ► Technische Chemie | |
Schlagworte | Biomedical and Life Sciences • immunology • infectious disease • Pharmaceutical Sciences/Technology • preventive vaccine • therapeutic cancer vaccines • Vaccine • vaccines • viral vector vaccine |
ISBN-10 | 3-7091-1980-4 / 3709119804 |
ISBN-13 | 978-3-7091-1980-8 / 9783709119808 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich